Icon Genetics And Novoplant GmbH Announce Broad License Agreement

Icon Genetics AG, Munich, and Novoplant GmbH, Gatersleben, announced in Ocotber that the two companies entered into a broad licensing agreement that gives Novoplant an access to Icon's proprietary technology platforms, Transgene Operating Systems®, for manufacturing immune response proteins in green plants. The agreement provides Novoplant with a strategically needed freedom to operate in its core business area, animal health. The financial terms of the agreement are not disclosed.